About Us
Founders
Mr and Mrs Lin are entrepreneurs with interests in the real estate and financial services sectors in countries all over the world including China, Malaysia, United States, Thailand, United Kingdom and Africa. They are also avid philanthropist supporting various foundations and charitable causes in Nepal and other parts of the world.
Lin Guan Zhi
Guan Zhi is a highly motivated and creative individual who is passionate about problem solving and their applications in the real world. Over the years, He has pursued an academic research career. Guan Zhi gained a BSc in Biochemistry from Birmingham University, having graduated with first class honours. He then pursued a PhD from Imperial College, where his research on high throughput screening for anti-cancer genes resulted in two patents.
Academic Publications
Replacement of GroEL in Escherichia coli by the Group II Chaperonin from the Archaeon Methanococcus maripaludis.
Shah R, Large AT, UrsinusA, Lin B, GowrinathanP, Martin J, Lund PA.
J Bacteriol. 2016 Sep 9;198(19):2692-700. doi: 10.1128/JB.00317-16. Print 2016 Oct 1.
De-ubiquitinating proteases USP2a and USP2c cause apoptosis by stabilising RIP1.
Mahul-MellierAL, Datler C, PazarentzosE, Lin B, ChaisaklertW, Abuali G, Grimm S.
Biochim Biophys Acta. 2012 Aug;1823(8):1353-65. Epub2012 May 30.
De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF.
Mahul-MellierAL, Pazarentzos E, DatlerC, Iwasawa R, AbuAliG, Lin B, Grimm S.
Cell Death Differ. 2012 May;19(5):891-9. doi: 10.1038/cdd.2011.185. Epub2011 Dec 16.
Determining signalling nodes for apoptosis by a genetic high-throughput screen.
Lin B, Huntley D, AbualiG, Langley SR, Sindelar G, PetrettoE, Butcher S, Grimm S.
PLoSOne. 2011;6(9):e25023. Epub2011 Sep 22.
Genetic cell culture screens reveal mitochondrial apoptosis control.
Grimm S, Lin B.
Front Biosci. 2009 Jan 1;14:1471-8.
Lin Guan Liang
Guan Liang serves as Chief Executive Officer of Technovative Group, Inc. where he’s responsible for the overall growth strategy of the Company. He also serves as an Executive Director of Moxian, Inc., a Nasdaq-listed company. He is also a Director of Asia Pacific at TAG Asia Partners LLC, a New York based boutique investment bank. Between 2012 to 2017, Mr. Lin was a Manager at 8i Capital Limited, where he was involved in advising businesses to list in the United States and London, fund-raising and restructuring work. During his time at 8i Capital, Mr. Lin also served as a Director at Rebel Group, Inc., where he was focused on restructuring the business for its listing in United States. Prior to 8i Capital, from 2011 to 2012, Mr. Lin was an analyst at Chance Investment Inc., advising Chinese businesses on acquisition and fund-raising. Until 2012, he was the legal associate at FM Holdings Limited, where he was actively involved in the company’s restructuring and debt-financing.
He graduated from Queen Mary, University of London with LLB in 2010.
Lin Guan Chen
Guan Chen holds a Master in Energy, Trade & Finance from Cass Business School (London). He started his career in futures and commodity trading with a US based trading firm.
Lin Guan Yang
Guan Yang is a financial services profesional, previously worked at HSBC and Société Générale. He graduated from Royal Holloway with a Masters in Economics. He is extremely passionate about voluntary work. He recently completed a Half Marathon to raise funds and awareness for AGE UK, leading charity for older people. He is currently working on several projects to help raise fund and support the local food banks during Covid 19 crisis.